DD202506A5 - Verfahren zur herstellung von reinem hepatitis b-oberflaechenantigen - Google Patents

Verfahren zur herstellung von reinem hepatitis b-oberflaechenantigen Download PDF

Info

Publication number
DD202506A5
DD202506A5 DD82240579A DD24057982A DD202506A5 DD 202506 A5 DD202506 A5 DD 202506A5 DD 82240579 A DD82240579 A DD 82240579A DD 24057982 A DD24057982 A DD 24057982A DD 202506 A5 DD202506 A5 DD 202506A5
Authority
DD
German Democratic Republic
Prior art keywords
hepatitis
plasma
proteins
hbsag
pepsin
Prior art date
Application number
DD82240579A
Other languages
German (de)
English (en)
Inventor
Witold Brzosko
Piotr Janicki
Zbigniew K Laskowski
Kazimierz Madalinski
Andrzej Dabrowa
Original Assignee
Akad Warszawie Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akad Warszawie Med filed Critical Akad Warszawie Med
Publication of DD202506A5 publication Critical patent/DD202506A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD82240579A 1981-06-10 1982-06-09 Verfahren zur herstellung von reinem hepatitis b-oberflaechenantigen DD202506A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL1981231588A PL133476B1 (en) 1981-06-10 1981-06-10 Method of obtaining pure antigen hba from human serum

Publications (1)

Publication Number Publication Date
DD202506A5 true DD202506A5 (de) 1983-09-21

Family

ID=20008812

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82240579A DD202506A5 (de) 1981-06-10 1982-06-09 Verfahren zur herstellung von reinem hepatitis b-oberflaechenantigen

Country Status (22)

Country Link
US (1) US4558011A (cs)
JP (1) JPS584729A (cs)
AU (1) AU8471282A (cs)
CA (1) CA1203169A (cs)
CH (1) CH650682A5 (cs)
CS (1) CS232726B2 (cs)
DD (1) DD202506A5 (cs)
DE (1) DE3221813A1 (cs)
DK (1) DK260482A (cs)
ES (1) ES8303916A1 (cs)
FI (1) FI822018A7 (cs)
FR (1) FR2507478A1 (cs)
GB (1) GB2099700B (cs)
HU (1) HU186864B (cs)
IT (1) IT1151793B (cs)
NO (1) NO821927L (cs)
PL (1) PL133476B1 (cs)
PT (1) PT75031B (cs)
RO (1) RO84231B (cs)
SE (1) SE8203435L (cs)
SU (1) SU1409121A3 (cs)
YU (1) YU116882A (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
US5242812A (en) * 1989-02-07 1993-09-07 Bio-Technology General Corp. Method for production and purification of hepatitis B vaccine
GB9822714D0 (en) 1998-10-16 1998-12-09 Smithkline Beecham Sa Vaccines
RU2166708C1 (ru) * 1999-11-01 2001-05-10 Военный инженерно-космический университет им. А.Ф. Можайского Высокоэффективная система длительного хранения сжиженных газов по схеме кириллова

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
DE2225548C3 (de) * 1972-05-26 1980-05-29 Behringwerke Ag, 3550 Marburg Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
SU810811A1 (ru) * 1979-02-19 1981-03-07 Институт Полиомиелита И Вирусныхэнцефалитов Amh Cccp Способ получени вируса гепатитаА

Also Published As

Publication number Publication date
GB2099700B (en) 1984-12-19
PT75031B (en) 1984-05-09
CS425482A2 (en) 1984-06-18
JPS584729A (ja) 1983-01-11
FR2507478B1 (cs) 1984-09-07
DE3221813A1 (de) 1983-02-17
CH650682A5 (de) 1985-08-15
PL231588A1 (cs) 1982-12-20
CA1203169A (en) 1986-04-15
SE8203435L (sv) 1982-12-11
FR2507478A1 (fr) 1982-12-17
US4558011A (en) 1985-12-10
CS232726B2 (en) 1985-02-14
PT75031A (en) 1982-07-01
YU116882A (en) 1985-03-20
PL133476B1 (en) 1985-06-29
DK260482A (da) 1982-12-11
RO84231B (ro) 1984-07-30
FI822018A0 (fi) 1982-06-07
NO821927L (no) 1982-12-13
ES512971A0 (es) 1983-02-16
FI822018A7 (fi) 1982-12-11
ES8303916A1 (es) 1983-02-16
RO84231A (ro) 1984-05-23
IT1151793B (it) 1986-12-24
AU8471282A (en) 1982-12-16
SU1409121A3 (ru) 1988-07-07
IT8221787A0 (it) 1982-06-09
GB2099700A (en) 1982-12-15
HU186864B (en) 1985-10-28

Similar Documents

Publication Publication Date Title
DE3209127C2 (cs)
DE2049515A1 (de) Impfstoff gegen Virushepatitis
DE2711773A1 (de) Verfahren zur reinigung und isolierung von hepatitisvirus zur herstellung eines impfstoffes
CH626256A5 (en) Device for the continuous, extracorporal separation of specific substances from blood
DE69012682T2 (de) Verfahren zur Entfernung von bakteriellen Endotoxinen aus gram-negativen Polysacchariden.
EP0173241B1 (de) Vakzine zur Behandlung der Harnwegsinfektionen
DE2457090C2 (de) Verfahren zur Herstellung von Impfstoffen sowie Antibronchialimpfstoff
DE2817871A1 (de) Verfahren und vorrichtung zur abtrennung und reinigung von proteinen durch chromatographie
DE2658170A1 (de) Arzneimittel zur behandlung der durch den hepatitisvirus b ausgeloesten akuten oder chronischen infektionen
DE2518474A1 (de) Mitogenes mittel, verfahren zu seiner herstellung und diese mittel enthaltende arzneimittel und biologische reagenzien
CH650682A5 (de) Verfahren zur herstellung von reinem hepatitis b antigen aus menschlichem plasma.
DE2732587C2 (cs)
DE1617332C3 (de) Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung
DE2845745C2 (cs)
DE2234832C2 (de) Proteinfreies Hormonkonzentrat von Säugetier-Nebenschilddrüsen, dessen Herstellung und dieses Hormonkonzentrat enthaltende pharmazeutische Präparate
DE2748520C2 (cs)
WO2001048476A2 (de) Gewinnung von biologischen komponenten aus körperflüssigkeiten
DE2528584A1 (de) Verfahren zur inaktivierung der virusinfektiositaet unter gleichzeitiger stabilisierung von virusantigenen
EP0183253B1 (de) Arzneimittel enthaltend einen aus den Peyer'schen Plaques hergestellten Organextrakt zur Behandlung bei Diabetes Mellitus und Pankreatitis
DE2353035A1 (de) Verfahren zur stabilisierung menschlicher oder tierischer koerperfluessigkeiten oder pflanzlicher extrakte
EP0141939A2 (de) Verfahren zur Herstellung von natürlichem Immunoadsorbens
DE3877102T2 (de) Methode fuer die behandlung von viraler gehirnentzuendung.
DE2134930A1 (de) Antigene Extrakte
CH652028A5 (de) Extrakt aus pflanzen vom genus epimedium sp., verfahren zur herstellung dieses extrakts und verwendung des extrakts als wirksame komponente in einem immunstimulierenden mittel.
DE2815758C3 (de) Peptidkomplexe aus DNS-haltigen Organismen